Moreover, survival rate and therapy responses partially depend on the abnormal ECM remodeling and its components, including cadherins, laminins, and integrins since it can influence drug penetration, tumor angiogenesis, endothelial and immune cells, eventually affecting tumor progression and aggressiveness [32,33]. This evidence concerns the gene LAMB2 and neoplasm.